Merck & Co. (NYSE: MRK) last traded at $147.28, up 3.73% on the session. The quote above updates while this page is open; the figures below are drawn from Merck & Co.’s own filings and are restated only when a new one is published.
Merck & Co. trades on NYSE under the ticker MRK. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $363.37 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Merck & Co., derived from the latest quote and its most recent SEC filing.
| Market cap | $363.37B |
|---|---|
| Enterprise value | $444.33B |
| P/E ratio | 117.82 |
| Price / sales | 5.46 |
| Price / book |
|---|
| 8.67 |
| Beta | 0.14 |
|---|
Trailing-twelve-month figures tagged in Merck & Co.'s XBRL filings with the SEC.
| Revenue (TTM) | $66.57B |
|---|---|
| Net income (TTM) | $3.17B |
| EPS (TTM) | $1.25 |
| Gross margin | 72.97% |
| Return on equity | 7.57% |
| Cash | $6.85B |
Range and volume for MRK over the past 52 weeks.
| 52-week high | $156.92 |
|---|---|
| 52-week low | $82.01 |
| Volume | 3.44M |
| Average volume | 9.73M |
| Previous close | $141.98 |
Dividend history for Merck & Co. over the trailing twelve months.
| Dividend yield | 2.28% |
|---|---|
| Dividend per share (TTM) | $3.36 |
| Payout ratio | 268.80% |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Merck & Co. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MRK.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.